Other grades of this product :
| (R)-(-)-IBUPROFEN Basic information |
| (R)-(-)-IBUPROFEN Chemical Properties |
| Melting point | 41-42°C | | Boiling point | 305.14°C (rough estimate) | | density | 1.0176 (rough estimate) | | refractive index | 1.5290 (estimate) | | storage temp. | Sealed in dry,2-8°C | | solubility | Chloroform (Slightly), Ethanol (Slightly), Methanol (Slightly) | | form | White crystalline powder. | | pka | 4.41±0.10(Predicted) | | color | Colourless to Pale Beige Oil | | Water Solubility | 369.3mg/L(25 ºC) |
| Safety Statements | 24/25 | | HS Code | 29155090 |
| (R)-(-)-IBUPROFEN Usage And Synthesis |
| Description | Ibuprofen is a non-steroidal anti-inflammatory drug with diverse biochemical actions, most notably inhibiting COX-1 and COX-2 (IC50s = 2.6 and 1.53 μM, respectively). It is commonly synthesized as a racemic mixture of (S) and (R) isomers (Item No. item 70280). (R)-Ibuprofen is an enantiomer that is generally not considered a COX inhibitor and is instead thought to be involved in pathways of lipid metabolism as it is incorporated into triglycerides along with fatty acids. The (R) enantiomer can, however, inhibit NF-κB activation (IC50 = 121.8 μM) in response to T-cell stimulation as well as block superoxide formation, β-glucuronidase release, and LTB4 generation by stimulated neutrophils (IC50 values range from 40-100 μM). 50-60% of (R)-ibuprofen is inverted to (S)-ibuprofen in humans after oral administration. | | Chemical Properties | White Crystalline Solid | | Uses | A nonsteroidal anti-inflammatory drug (NSAID); activity resides primarily in the (S)-isomer | | Uses | A nonsteroidal anti-inflammatory drug (NSAID); activity resides primarily in the (S)-isomer. | | Purification Methods | Crystallise the (+) and (-) acids from EtOH or aqueous EtOH. The racemate which crystallises from pet ether with m 75-77o is sparingly soluble in H2O and has IR (film) 1705 (C=O), 2300—3700 (OH broad)cm-1. It is used as a non-steroidal anti-inflammatory. [Shiori et al. J Org Chem 43 2936 1978, Kaiser et al. J Pharm Sci 65 269 1976, J Pharm Sci 81 221 1992, Freer Acta Cryst (C) 49 1378 1993 for the (S+)-enantiomer.] |
| (R)-(-)-IBUPROFEN Preparation Products And Raw materials |
|
日本语
한국어
Français
Deutsch
España
Türkiye